Examples
| Generic Name | Brand Name |
|---|
| adalimumab | Humira |
Adalimumab is given as a shot under the skin (subcutaneous
injection).
How It Works
Adalimumab reduces the effects of tumor necrosis factor (TNF). TNF
is produced in your body in times of
inflammation and attaches to the joint surface,
causing damage to soft tissues, cartilage, and bones. Adalimumab is a
disease-modifying antirheumatic drug (DMARD), which means it slows the
progression of
rheumatoid arthritis. DMARDs are also called
immunosuppressive drugs or slow-acting antirheumatic drugs (SAARDs).
Why It Is Used
Adalimumab has been approved for use in treating adults with
moderate to severe rheumatoid arthritis. Adalimumab may be used alone or in
combination with other DMARDs such as methotrexate.1
How Well It Works
Adalimumab appears to work rapidly and is well-tolerated. A
clinical trial of adalimumab used in combination with methotrexate found a 20%
improvement in 67% of people who were given the medication, with improvements noticeable
after 1 week of treatment.2 In another study of
adalimumab used alone, researchers report significant, rapid, sustained
reductions in disease activity and improved physical function, including
reduced swelling and pain.3
Side Effects
Cases of serious, even fatal, infections have been reported during
treatment with adalimumab.
Risk of infection
Adalimumab decreases the activity of your body's immune system,
which increases the risk of a serious bacterial infection. Some people who take
adalimumab develop an infection that requires oral antibiotics; a smaller
number of people will develop an infection that requires intravenous
antibiotics and hospitalization. Contact your health professional if you
develop any of the following symptoms:
- Fever or chills
- Increased
frequency of or burning during urination
- A cough with yellow
sputum or shortness of breath
- A skin
infection
- Severe abdominal pain or diarrhea
- A severe
sore throat
- Sinus pain with yellow
mucus
- A painful, burning rash in a band
across one side of your body (shingles)
- Painful,
widespread mouth sores
Other side effects may include:
- Allergic reactions.
- Pain at the
injection site.
- Nausea.
- Flu-like symptoms.
Adalimumab can reactivate
tuberculosis (TB) in people who have been previously
infected with TB. Before starting adalimumab treatment, you should be screened
with a tuberculin skin test and/or a chest X-ray. If the skin test is positive
or the chest X-ray suggests a prior history of exposure to TB, you will need
treatment to prevent active TB.1
People with rheumatoid arthritis have a slightly higher risk of getting cancer of the lymph glands, called lymphoma, than people without rheumatoid arthritis. But lymphoma is rare even for people with rheumatoid arthritis. Experts do not know why this risk is higher for people with rheumatoid arthritis—it may be because the disease is severe or because of the medicines used to treat it. Studies are currently under way to explain this. Talk with your doctor about the benefits and risks of DMARD therapy.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
Adalimumab is a new TNF inhibitor, approved by the U.S. Food and
Drug Administration. Like etanercept and infliximab, adalimumab is
significantly more expensive than DMARDs such as methotrexate and
sulfasalazine.1
Adalimumab should not be used by pregnant women or women of
childbearing age who are not using reliable birth control. If you are going to
take adalimumab, you should be on some form of reliable birth control. If you
plan to become pregnant, check with your health professional before
stopping birth control and trying to become pregnant.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.